These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15108458

  • 1. [Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension].
    Arkhipova DV, Privalova EV, Kozlovskaia LV, Kornev BM, Popova EN, Kraeva VV, Osipenko VI, Bitsadze VO.
    Ter Arkh; 2004; 76(3):43-9. PubMed ID: 15108458
    [Abstract] [Full Text] [Related]

  • 2. [Vasaprostan treatment of fibrosing alveolitis in patients with pulmonary hypertension].
    Popova EN, Bolevich SB, Litvitskiĭ PF, Arkhipova DV, Osipenko VI, Kogan EA, Kornev BM, Mukhin NA.
    Ter Arkh; 2004; 76(8):56-61. PubMed ID: 15471399
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis.
    Cuderman TV, Bozic M, Peternel P, Stegnar M.
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):55-62. PubMed ID: 17895509
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 Jan; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Doppler echocardiography-right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension.
    Swanson KL, Utz JP, Krowka MJ.
    Med Sci Monit; 2008 Apr; 14(4):CR177-82. PubMed ID: 18376344
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.
    Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J.
    Am J Respir Crit Care Med; 2004 Aug 15; 170(4):360-5. PubMed ID: 15087298
    [Abstract] [Full Text] [Related]

  • 18. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S.
    Rinsho Byori; 2004 Apr 15; 52(4):355-61. PubMed ID: 15164605
    [Abstract] [Full Text] [Related]

  • 19. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I, Wysokin Ski W, Karnicki K, Adamiec R.
    Int Angiol; 2008 Aug 15; 27(4):296-301. PubMed ID: 18677291
    [Abstract] [Full Text] [Related]

  • 20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 15; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.